Jupiter Neurosciences (JUNS) EBIT Margin (2026)
Jupiter Neurosciences' (JUNS) quarterly EBIT Margin came in at 11313.45% in Q2 2026.
Powered by 
Analysis
Jupiter Neurosciences (JUNS) EBIT Margin (2026) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported EBIT Margin for 1 consecutive years, with 11313.45% the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.23 Bn | 68.86 Bn | 3.30 Bn | 18.95% |
| 2 | Kenvue | 34.13 Bn | 33.02 Bn | 2.30 Bn | 17.67% |
| 3 | Kimberly Clark | 32.73 Bn | 31.77 Bn | 1.60 Bn | 15.11% |
| 4 | Bath & Body Works | 3.77 Bn | 2.98 Bn | 692.00 Mn | 14.27% |
| 5 | Prestige Consumer Healthcare | 2.27 Bn | 2.21 Bn | - | - |
| 6 | Perrigo | 1.89 Bn | 1.49 Bn | 313.90 Mn | 2.30% |
| 7 | Herbalife | 1.28 Bn | 905.45 Mn | 1.03 Bn | 9.67% |
| 8 | Edgewell Personal Care | 1.24 Bn | 840.59 Mn | 242.50 Mn | 4.39% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Jupiter Neurosciences | 1.75 Mn | 223,310.77 | 21,064.00 | -11,313.45% |